Episode: 27 - Law to Biotech: Joseph La Barge on Starting a Company and the Future of Gene Therapy
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
Episode: 27 - Law to Biotech: Joseph La Barge on Starting a Company and the Future of Gene Therapy
-
Narrated by:
-
By:
About this listen
In this month’s episode of Trends from the Trenches, host Stan Gloss speaks with Joseph La Barge. La Barge trained as an attorney but has spent most of his career building biotech businesses and securing funding. He shepherded Spark Therapeutics through its acquisition by Roche and has since joined Apertura Gene Therapy as CEO. He and Stan talk about the entrepreneurship journey, gene expression and capsid engineering, and Apertura’s future goals and projects.
Links from this episode:
Bio-IT World
BioTeam
Bio-IT World Europe
Apertura Gene Therapy
Trends from the Trenches boiler: Bio-IT World’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders. BioTeam co-founder Stan Gloss brings years of industry experience in science, data, and technology to conversations exploring what is driving data and discovery, and what’s coming next.